Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of a Network Platform for Fertility-sparing in Patients With Endometrial Cancer and Study on Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer.

NCT05945407 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05945407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of a Network Platform for Fertility-sparing in Patients With Endometrial Cancer and Study on Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer.
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2016
Completion date
December 31, 2027
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, endometrioid, endometrial neoplasm malignant, endometrial neoplasm malignant stage i, endometrial neoplasms, fertility preservation